Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model

Joy L. Kovar, Mark A. Johnson, William M. Volcheck, Jiyan Chen, Melanie A Simpson

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Molecular mechanisms of prostate cancer progression are frequently studied in mice by orthotopic injection of aggressive cell lines, which yield primary tumors that spontaneously metastasize to lymph nodes. In this report, we characterized the human prostate carcinoma cell line 22Rv1 in an orthotopic system and evaluated the functional relevance of the hyaluronidase Hyal1, a correlate of invasive human prostate cancer, to progression in this model. To provide real-time insights into these processes, we first validated use of an epidermal growth factor-conjugated fluorophore to illuminate orthotopic prostate tumors and their metastases in whole animal imaging. Animals receiving intraprostatic injections were tracked throughout a 6-week period. Tumor sizes were correlated 92% with total fluorescence intensities of 22 prostate tumors. In contrast to the highly tumorigenic and metastatic PC3M-LN4 cells, the 22Rv1 line was orthotopically tumorigenic but not metastatic, despite larger tumor sizes. Lymph node metastasis was successfully imaged in animals with PC3M-LN4 tumors on endpoint dissection. Stable transfection of 22Rv1 cells with Hyal1 did not alter growth kinetics of primary orthotopic tumors, but all animals implanted with Hyal1 transfectants exhibited tumor-positive para-aortic lymph nodes. Hyal1 is implicated as an inducer of prostate cancer metastatic progression.

Original languageEnglish (US)
Pages (from-to)1415-1426
Number of pages12
JournalAmerican Journal of Pathology
Volume169
Issue number4
DOIs
StatePublished - Jan 1 2006

Fingerprint

Hyaluronoglucosaminidase
Prostate
Neoplasm Metastasis
Neoplasms
Prostatic Neoplasms
Lymph Nodes
Cell Line
Injections
Epidermal Growth Factor
Transfection
Dissection
Fluorescence
Carcinoma
Growth

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. / Kovar, Joy L.; Johnson, Mark A.; Volcheck, William M.; Chen, Jiyan; Simpson, Melanie A.

In: American Journal of Pathology, Vol. 169, No. 4, 01.01.2006, p. 1415-1426.

Research output: Contribution to journalArticle

Kovar, Joy L. ; Johnson, Mark A. ; Volcheck, William M. ; Chen, Jiyan ; Simpson, Melanie A. / Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. In: American Journal of Pathology. 2006 ; Vol. 169, No. 4. pp. 1415-1426.
@article{d1029c34bae742feac4b63e19961483f,
title = "Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model",
abstract = "Molecular mechanisms of prostate cancer progression are frequently studied in mice by orthotopic injection of aggressive cell lines, which yield primary tumors that spontaneously metastasize to lymph nodes. In this report, we characterized the human prostate carcinoma cell line 22Rv1 in an orthotopic system and evaluated the functional relevance of the hyaluronidase Hyal1, a correlate of invasive human prostate cancer, to progression in this model. To provide real-time insights into these processes, we first validated use of an epidermal growth factor-conjugated fluorophore to illuminate orthotopic prostate tumors and their metastases in whole animal imaging. Animals receiving intraprostatic injections were tracked throughout a 6-week period. Tumor sizes were correlated 92{\%} with total fluorescence intensities of 22 prostate tumors. In contrast to the highly tumorigenic and metastatic PC3M-LN4 cells, the 22Rv1 line was orthotopically tumorigenic but not metastatic, despite larger tumor sizes. Lymph node metastasis was successfully imaged in animals with PC3M-LN4 tumors on endpoint dissection. Stable transfection of 22Rv1 cells with Hyal1 did not alter growth kinetics of primary orthotopic tumors, but all animals implanted with Hyal1 transfectants exhibited tumor-positive para-aortic lymph nodes. Hyal1 is implicated as an inducer of prostate cancer metastatic progression.",
author = "Kovar, {Joy L.} and Johnson, {Mark A.} and Volcheck, {William M.} and Jiyan Chen and Simpson, {Melanie A}",
year = "2006",
month = "1",
day = "1",
doi = "10.2353/ajpath.2006.060324",
language = "English (US)",
volume = "169",
pages = "1415--1426",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model

AU - Kovar, Joy L.

AU - Johnson, Mark A.

AU - Volcheck, William M.

AU - Chen, Jiyan

AU - Simpson, Melanie A

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Molecular mechanisms of prostate cancer progression are frequently studied in mice by orthotopic injection of aggressive cell lines, which yield primary tumors that spontaneously metastasize to lymph nodes. In this report, we characterized the human prostate carcinoma cell line 22Rv1 in an orthotopic system and evaluated the functional relevance of the hyaluronidase Hyal1, a correlate of invasive human prostate cancer, to progression in this model. To provide real-time insights into these processes, we first validated use of an epidermal growth factor-conjugated fluorophore to illuminate orthotopic prostate tumors and their metastases in whole animal imaging. Animals receiving intraprostatic injections were tracked throughout a 6-week period. Tumor sizes were correlated 92% with total fluorescence intensities of 22 prostate tumors. In contrast to the highly tumorigenic and metastatic PC3M-LN4 cells, the 22Rv1 line was orthotopically tumorigenic but not metastatic, despite larger tumor sizes. Lymph node metastasis was successfully imaged in animals with PC3M-LN4 tumors on endpoint dissection. Stable transfection of 22Rv1 cells with Hyal1 did not alter growth kinetics of primary orthotopic tumors, but all animals implanted with Hyal1 transfectants exhibited tumor-positive para-aortic lymph nodes. Hyal1 is implicated as an inducer of prostate cancer metastatic progression.

AB - Molecular mechanisms of prostate cancer progression are frequently studied in mice by orthotopic injection of aggressive cell lines, which yield primary tumors that spontaneously metastasize to lymph nodes. In this report, we characterized the human prostate carcinoma cell line 22Rv1 in an orthotopic system and evaluated the functional relevance of the hyaluronidase Hyal1, a correlate of invasive human prostate cancer, to progression in this model. To provide real-time insights into these processes, we first validated use of an epidermal growth factor-conjugated fluorophore to illuminate orthotopic prostate tumors and their metastases in whole animal imaging. Animals receiving intraprostatic injections were tracked throughout a 6-week period. Tumor sizes were correlated 92% with total fluorescence intensities of 22 prostate tumors. In contrast to the highly tumorigenic and metastatic PC3M-LN4 cells, the 22Rv1 line was orthotopically tumorigenic but not metastatic, despite larger tumor sizes. Lymph node metastasis was successfully imaged in animals with PC3M-LN4 tumors on endpoint dissection. Stable transfection of 22Rv1 cells with Hyal1 did not alter growth kinetics of primary orthotopic tumors, but all animals implanted with Hyal1 transfectants exhibited tumor-positive para-aortic lymph nodes. Hyal1 is implicated as an inducer of prostate cancer metastatic progression.

UR - http://www.scopus.com/inward/record.url?scp=33845877573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845877573&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2006.060324

DO - 10.2353/ajpath.2006.060324

M3 - Article

VL - 169

SP - 1415

EP - 1426

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -